Although AOA is a pan-aminotransferase inhibitor, our data clearly demonstrate that the tumour inhibitory effect of AOA on PIK3CA mutant xenografts is indeed on-target to GPT2, because GPT2 knockdown cells grow much slower in nude nice and these tumours are insensitive to AOA treatment. The gene discussed is PIK3CA; the disease is neoplasm.